Commentary: Policy changes would help biotech sector

02/17/2009 | Scientist online (free registration), The

The biotech industry requires vital changes in government policies instead of a bailout because most companies operate mainly as "science projects" that would benefit more from increased funding than keeping their infrastructure, writes Stephanie Marrus, a life sciences management consultant. The government could help the sector by choosing a respected FDA leader and refraining from drug-price controls, Marrus writes.

View Full Article in:

Scientist online (free registration), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC